参考文献
1: Hammond SL, Safe S, Tjalkens RB. A novel synthetic activator of Nurr1 induces
dopaminergic gene expression and protects against 6-hydroxydopamine neurotoxicity
in vitro. Neurosci Lett. 2015 Oct 21;607:83-9. doi: 10.1016/j.neulet.2015.09.015.
Epub 2015 Sep 14. PubMed PMID: 26383113; PubMed Central PMCID: PMC4631643.
2: De Miranda BR, Popichak KA, Hammond SL, Jorgensen BA, Phillips AT, Safe S,
Tjalkens RB. The Nurr1 Activator 1,1-Bis(3'-Indolyl)-1-(p-Chlorophenyl)Methane
Blocks Inflammatory Gene Expression in BV-2 Microglial Cells by Inhibiting
Nuclear Factor κB. Mol Pharmacol. 2015 Jun;87(6):1021-34. doi:
10.1124/mol.114.095398. Epub 2015 Apr 9. PubMed PMID: 25858541; PubMed Central
PMCID: PMC4429718.
3: De Miranda BR, Popichak KA, Hammond SL, Miller JA, Safe S, Tjalkens RB. Novel
para-phenyl substituted diindolylmethanes protect against MPTP neurotoxicity and
suppress glial activation in a mouse model of Parkinson's disease. Toxicol Sci.
2015 Feb;143(2):360-73. doi: 10.1093/toxsci/kfu236. Epub 2014 Nov 17. PubMed
PMID: 25406165; PubMed Central PMCID: PMC4306720.
4: De Miranda BR, Miller JA, Hansen RJ, Lunghofer PJ, Safe S, Gustafson DL,
Colagiovanni D, Tjalkens RB. Neuroprotective efficacy and pharmacokinetic
behavior of novel anti-inflammatory para-phenyl substituted diindolylmethanes in
a mouse model of Parkinson's disease. J Pharmacol Exp Ther. 2013
Apr;345(1):125-38. doi: 10.1124/jpet.112.201558. Epub 2013 Jan 14. PubMed PMID:
23318470.
